Clinical trial
Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma
NCT00002909 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00002909 |
|---|---|
| Title | Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma |
| Official title | A PHASE I CLINICAL AND PHARMACOLOGIC EVALUATION OF PHENYLBUTYRATE IN PATIENTS WITH REFRACTORY SOLID TUMORS: STUDY OF CONTINUOUS EXPOSURE ORAL PHENYLBUTYRATE ON A THREE TIMES DAILY SCHEDULE |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | chemotherapy, oral sodium phenylbutyrate |
| Enrollment | 24 |
| Start date | Feb 1, 1997 |
| Primary completion | Oct 1, 2000 |
| First posted | Aug 11, 2004 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: